 Precipio stock rocketed higher for a second session on Tuesday, with a fivefold surge in the price ignited after the specialty diagnostics company launched its COVID-19 antibody test on Amazon. The company said it holds the exclusive rights to distribute the 20-minute test on Amazons platform. Precipio said the test, which covers two types of antibodies, was visible for sale on the retailing giants website and app. 